1H-MR spectroscopy metabolite levels correlate with executive function in vascular cognitive impairment

Charles Gasparovic1, Jillian Prestopnik, Jeffrey Thompson

  • 1Department of Neurology, University of New Mexico Health Sciences Center, Albuquerque, NM 87131-0001, USA.

Abstract

Insights

Brain metabolite levels, measured by proton MR spectroscopy, better predict cognitive function in vascular cognitive impairment (VCI) than white matter hyperintensities (WMHs). This finding offers new insights into VCI assessment.

Area of Science:

  • Neuroimaging
  • Neurology
  • Biochemistry

Background:

  • White matter hyperintensities (WMHs) are linked to vascular cognitive impairment (VCI) but show weak correlations with cognitive tests.
  • Proton MR spectroscopy ((1)H-MRS) can detect ischemic changes in brain tissue.

Purpose of the Study:

  • To investigate if brain metabolites detected by (1)H-MRS are superior to WMHs in predicting neuropsychological test performance in patients with suspected VCI.

Main Methods:

  • Sixty patients with suspected VCI underwent clinical, neuropsychological, MRI, and CSF assessments.
  • (1)H-MRS was used to measure brain metabolites in white matter; WMH volume was also quantified.
  • Patients were diagnosed with subcortical ischemic vascular disease (SIVD), multiple infarcts, mixed dementia, or leukoaraiosis.

Main Results:

  • Significant correlations were found between creatine (Cr) and N-acetylaspartyl compounds (NAA) and neuropsychological test scores.
  • Cr levels correlated with executive function and attention; NAA correlated with executive function.
  • Lesion volume alone did not significantly correlate with any neuropsychological test score, while metabolite levels did.

Conclusions:

  • Neurometabolite levels provide valuable information about cognitive function in VCI.
  • This information is not fully captured by lesion load measurements.
  • Lower metabolite levels and cognitive scores were observed in the SIVD group.

Related Concept Videos